| Lipids Management |
1 |
1 |
| Cardiac Surgery |
0 |
0.87 |
| Cardiovascular Risk Management |
0 |
0.64 |
| Cerebrovascular Accident |
0 |
0.61 |
| Thromboembolism |
0 |
0.56 |
| Clinical Guidelines |
0 |
0.54 |
| Congenital Heart Disease |
0 |
0.54 |
| Aortic Stenosis |
0 |
0.46 |
| Blood |
0 |
0.43 |
| Healthcare and Medical Technology |
0 |
0.36 |
| Stenosis |
0 |
0.33 |
| Endarterectomy |
0 |
0.26 |
| Coronary Artery Disease (CAD) |
0 |
0.23 |
| Clinical Research |
0 |
0.22 |
| LDL Cholesterol |
0 |
0.22 |
| In-Stent Restenosis |
0 |
0.19 |
| Genomic Medicine |
0 |
0.18 |
| Revenue and Practice Management |
0 |
0.18 |
| Social Determinants of Health |
0 |
0.18 |
| Artery |
0 |
0.11 |
| Biomarker |
0 |
0.11 |
| Cardiovascular disease |
0 |
0.11 |
| Europe |
0 |
0.11 |
| Financial Reimbursement |
0 |
0.11 |
| Health Care Economics |
0 |
0.11 |
| Inheritance |
0 |
0.11 |
| Percutaneous Coronary Intervention |
0 |
0.11 |
| Plasma |
0 |
0.11 |
| Restenosis |
0 |
0.11 |
| Statins |
0 |
0.11 |
| Stent |
0 |
0.11 |
| Surgery |
0 |
0.11 |
| UK Site Content |
0 |
0.11 |